Literature DB >> 26503805

Pediatric Ependymoma.

Nicholas A Vitanza1, Sonia Partap2.   

Abstract

Over the past 150 years since Virchow's initial characterization of ependymoma, incredible efforts have been made in the classification of these tumors and in the care of pediatric patients with this disease. While the advent of modern neurosurgery and the optimization of radiation have provided significant gains, a more complex but incomplete picture of pediatric ependymomas has begun to form through a combination of international collaborations and detailed genetic and histologic characterizations. This review includes and synthesizes the clinical understanding of pediatric ependymoma and their developing molecular insight into what is truly a family of malignancies in which distinct members require different surgical approaches, radiation plans, and targeted therapies.
© The Author(s) 2015.

Entities:  

Keywords:  central nervous system cancer; childhood brain tumor

Mesh:

Year:  2015        PMID: 26503805     DOI: 10.1177/0883073815610428

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  12 in total

1.  Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

Authors:  Gabrielle Truitt; Haley Gittleman; Rebecca Leece; Quinn T Ostrom; Carol Kruchko; Terri S Armstrong; Mark R Gilbert; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2019-06-17       Impact factor: 4.130

2.  Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling.

Authors:  Ross Mangum; Jacquelyn Reuther; Kelsey C Bertrand; Raghu Chandramohan; Marcia K Kukreja; Arnold C Paulino; Donna Muzny; Jianhong Hu; Richard A Gibbs; Daniel J Curry; Fatema Malbari; Murali M Chintagumpala; Adekunle M Adesina; Kevin E Fisher; Stephen C Mack; Sharon E Plon; Angshumoy Roy; D Williams Parsons; Frank Y Lin
Journal:  JCO Precis Oncol       Date:  2021-07-28

Review 3.  Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors.

Authors:  Andrew Groves; Jessica Clymer; Mariella G Filbin
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-26

Review 4.  Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Authors:  Sebastian Zahnreich; Heinz Schmidberger
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

5.  Cerebrospinal fluid and intraoperative squash cytology of childhood ependymoma.

Authors:  Alexandra Kalogeraki; Dimitrios Tamiolakis; Eleni Moustou; Ioannis Panayiotides; Andreas Yannopoulos; Antonios Vakis; Nikolaos Katzilakis; Eftichia Stiakaki
Journal:  Acta Biomed       Date:  2021-05-12

Review 6.  Glioma: experimental models and reality.

Authors:  Krissie Lenting; Roel Verhaak; Mark Ter Laan; Pieter Wesseling; William Leenders
Journal:  Acta Neuropathol       Date:  2017-01-10       Impact factor: 17.088

7.  The role of postoperative radiotherapy in pediatric patients with grade II intracranial ependymomas: a population-based, propensity score-matched study.

Authors:  Xiangyang Deng; Dongdong Lin; Lisheng Yu; Xingxing Xu; Nu Zhang; Hui Zhou; Hansong Sheng; Bo Yin; Fengchun Lin; Shangyu Xu; Dandong Li; Junhao Fang; Xiangqi Lu; Jian Lin
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

Review 8.  In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview.

Authors:  Zhiqin Li; Sigrid A Langhans
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

9.  Personalizing age-specific survival prediction and risk stratification in intracranial grade II/III ependymoma.

Authors:  Xiangyang Deng; Xiaojia Zhang; Liang Yang; Xiangqi Lu; Junhao Fang; Lisheng Yu; Dandong Li; Hansong Sheng; Bo Yin; Nu Zhang; Jian Lin
Journal:  Cancer Med       Date:  2019-12-03       Impact factor: 4.452

Review 10.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.